Literature DB >> 35220890

LncRNA RUNX1-IT1 affects the differentiation of Th1 cells by regulating NrCAM transcription in Graves' disease.

Feng-Jiao Huang1, Yan-Ling Liu1, Jiao Wang1, Ying-Ying Zhou1, Shui-Ying Zhao1, Gui-Jun Qin1.   

Abstract

Graves' disease (GD) is a kind of autoimmune diseases. The development of GD is closely related to the imbalance of Th1/Th2 generated by the differentiation of CD4+ T cells. This study was sought to clarify the role of lncRNA RUNX1-IT1 and explore the mechanism of its function. The expressions of RUNX1-IT1 and Neural cell adhesion molecule (NrCAM) in the peripheral blood of GD patients were detected by qRT-PCR and Western blot. We performed RNA pull down, RIP, and ChIP experiments to verify the correlation between p53 and RUNX1-IT1, p53 and NrCAM. The levels of Th1 cells differentiation markers were detected by Flow cytometry assay and ELISA. The expressions of lncRNA RUNX1-IT1 and NrCAM were most significantly up-regulated in CD4+ T cells of GD patients, and NrCAM expression was significantly positively correlated with RUNX1-IT1 expression. Furthermore, p53 was a potential transcription factor of NrCAM, which could interact with NrCAM. NrCAM level was up-regulated after the overexpression of p53 in CD4+ T cells, while knockdown of RUNX1-IT1 reversed this effect. Down-regulation of NrCAM and RUNX1-IT1 could decrease the mRNA and protein levels of transcriptional regulator T-bet and CXC chemokine ligand 10 (CXCL10) in CD4+ T cells. Our results suggested that RUNX1-IT1 regulated the expressions of the important Th1 factor T-bet, CXCL10, and interferon γ (IFN-γ) by regulating NrCAM transcription, thus participating in the occurrence and development of specific autoimmune disease GD.

Entities:  

Keywords:  Graves’ disease; NrCAM; Th1 cells; lncRNA RUNX1-IT1

Mesh:

Substances:

Year:  2022        PMID: 35220890      PMCID: PMC9037574          DOI: 10.1080/15384101.2022.2034431

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  28 in total

1.  Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis.

Authors:  Yanfang Zhang; Fang Sui; Jingjing Ma; Xiaojuan Ren; Haixia Guan; Qi Yang; Jing Shi; Meiju Ji; Bingyin Shi; Yue Sun; Peng Hou
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

2.  Non-coding RNA: a new frontier in regulatory biology.

Authors:  Xiang-Dong Fu
Journal:  Natl Sci Rev       Date:  2014-06-01       Impact factor: 17.275

3.  Th1 Chemokines in Autoimmune Endocrine Disorders.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Francesca Ragusa; Ilaria Ruffilli; Giusy Elia; Sabrina Rosaria Paparo; Alessandro Antonelli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration.

Authors:  Jinxin Shi; Xi Zhong; Yongxi Song; Zhonghua Wu; Peng Gao; Junhua Zhao; Jingxu Sun; Jiajun Wang; Jingjing Liu; Zhenning Wang
Journal:  Cell Biochem Funct       Date:  2018-11-30       Impact factor: 3.685

5.  Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases.

Authors:  Naoya Inoue; Mikio Watanabe; Azusa Nakaguchi; Daishi Ueda; Hayaka Kawaguti; Yoh Hidaka; Yoshinori Iwatani
Journal:  Endocr J       Date:  2017-05-16       Impact factor: 2.349

6.  Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease.

Authors:  Janaina Luisa Leite; Natassia Elena Bufalo; Roberto Bernardo Santos; João Hamilton Romaldini; Laura Sterian Ward
Journal:  Eur J Endocrinol       Date:  2009-11-10       Impact factor: 6.664

7.  The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation.

Authors:  Pin Wang; Yiquan Xue; Yanmei Han; Li Lin; Cong Wu; Sheng Xu; Zhengping Jiang; Junfang Xu; Qiuyan Liu; Xuetao Cao
Journal:  Science       Date:  2014-04-18       Impact factor: 47.728

8.  LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.

Authors:  Liankang Sun; Liang Wang; Tianxiang Chen; Yu Shi; Bowen Yao; Zhikui Liu; Yufeng Wang; Qing Li; Runkun Liu; Yongshen Niu; Kangsheng Tu; Qingguang Liu
Journal:  Cell Death Dis       Date:  2020-02-05       Impact factor: 8.469

9.  Decreased SIRT1 expression in the peripheral blood of patients with Graves' disease.

Authors:  Qinglei Yin; Liyun Shen; Yicheng Qi; Dalong Song; Lei Ye; Ying Peng; Yanqiu Wang; Zhou Jin; Guang Ning; Weiqing Wang; Dongping Lin; Shu Wang
Journal:  J Endocrinol       Date:  2020-08       Impact factor: 4.286

10.  The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion.

Authors:  Songsong Liu; Junfeng Zhang; Liangyu Yin; Xianxing Wang; Yao Zheng; Yujun Zhang; Jianyou Gu; Ludi Yang; Jiali Yang; Ping Zheng; Yan Jiang; Ling Shuai; Xiongwei Cai; Huaizhi Wang
Journal:  Cell Death Dis       Date:  2020-06-02       Impact factor: 8.469

View more
  1 in total

1.  Comprehensive Analysis of lncRNA Expression Profile and the Potential Role of ENST00000604491 in Graves' Disease.

Authors:  Yingzhao Liu; Junli Zou; Juan Xu; Xuehua Wang; Jie Xing; Li Wang; Huiyong Peng
Journal:  J Immunol Res       Date:  2022-04-25       Impact factor: 4.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.